Valganciclovir as Add-On Therapy Modifies the Frequency of NK and NKT Cell Subpopulations in Disseminated Kaposi Sarcoma Patients

Valganciclovir as Add-On Therapy Modifies the Frequency of NK and NKT Cell Subpopulations in Disseminated Kaposi Sarcoma Patients

Human herpesvirus-8 infection (HHV-8) is the causative agent of Kaposi sarcoma (KS) and is highly prevalent among people living with HIV (KS/HIV). It has been reported that valganciclovir (VGC) reduces HHV-8 replication in KS/HIV patients. However, currently it is unclear if VGC modifies the frequen...

Full description

Bibliographic Details
Main Authors: Julio Flores-Gonzalez, Lucero A. Ramon-Luing, Ranferi Ocaña-Guzman, Ivette Buendia-Roldan, Beda Islas-Muñoz, Patricia Volkow-Fernández, Leslie Chavez-Galan
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Cancers
Subjects:
valganciclovir
kaposi sarcoma
human herpesvirus 8
HIV
natural killer cells
natural killer T-cells
Online Access:https://www.mdpi.com/2072-6694/14/2/412

Internet

https://www.mdpi.com/2072-6694/14/2/412

Similar Items